Form 8-K - Current report:
SEC Accession No. 0001698530-25-000047
Filing Date
2025-06-10
Accepted
2025-06-10 16:47:29
Documents
14
Period of Report
2025-06-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K xcur-20250606.htm   iXBRL 8-K 26623
2 EX-10.1 ex101-firstamendmenttoempl.htm EX-10.1 19640
3 EX-10.2 ex102-firstamendmenttoempl.htm EX-10.2 19715
  Complete submission text file 0001698530-25-000047.txt   192978

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xcur-20250606.xsd EX-101.SCH 1788
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xcur-20250606_lab.xml EX-101.LAB 22548
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xcur-20250606_pre.xml EX-101.PRE 13050
16 EXTRACTED XBRL INSTANCE DOCUMENT xcur-20250606_htm.xml XML 2813
Mailing Address 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address 2430 N. HALSTED ST. CHICAGO IL 60614 847-673-1707
EXICURE, INC. (Filer) CIK: 0001698530 (see all company filings)

EIN.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39011 | Film No.: 251037763
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)